Truist Securities Maintains Buy on HCA Healthcare, Lowers Price Target to $495

Benzinga · 2d ago
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $535 to $495.